Detailed price information for Jupiter Neurosciences Inc (JUNS-Q) from The Globe and Mail including charting and trades.
The amendment relates solely to installment timing and application mechanics and does not alter the underlying economic terms of the financing. “This amendment reflects a deliberate and aligned ...
JUPITER, FL / ACCESS Newswire / January 27, 2026 / Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform for ...
JUPITER, FL, UNITED STATES, February 25, 2026 /EINPresswire.com/ — Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results